Claus Harder

691 total citations
15 papers, 542 citations indexed

About

Claus Harder is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Claus Harder has authored 15 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 6 papers in Cardiology and Cardiovascular Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Claus Harder's work include Coronary Interventions and Diagnostics (11 papers), Cardiac Valve Diseases and Treatments (3 papers) and Peripheral Artery Disease Management (2 papers). Claus Harder is often cited by papers focused on Coronary Interventions and Diagnostics (11 papers), Cardiac Valve Diseases and Treatments (3 papers) and Peripheral Artery Disease Management (2 papers). Claus Harder collaborates with scholars based in Germany, United States and France. Claus Harder's co-authors include David Hellinga, Sonja Hartwig, Ron Waksman, Rajbabu Pakala, Eric Wittchow, Karl-Heinz Waldmann, Richard Baffour, Fermin O. Tio, Rufus Seabron and Pramod K. Kuchulakanti and has published in prestigious journals such as PLoS ONE, Acta Materialia and Journal of Controlled Release.

In The Last Decade

Claus Harder

15 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claus Harder Germany 9 271 237 216 174 84 15 542
J Verbist Belgium 6 265 1.0× 141 0.6× 202 0.9× 118 0.7× 42 0.5× 7 416
Koen Deloose Belgium 7 266 1.0× 171 0.7× 201 0.9× 118 0.7× 38 0.5× 17 433
Ankur Raval India 11 168 0.6× 137 0.6× 69 0.3× 55 0.3× 32 0.4× 26 431
Hao‐Ming Hsiao Taiwan 11 84 0.3× 163 0.7× 87 0.4× 57 0.3× 54 0.6× 31 415
Arnim Andreae Germany 9 212 0.8× 113 0.5× 195 0.9× 105 0.6× 31 0.4× 10 433
Jingzhu Duan China 9 187 0.7× 115 0.5× 213 1.0× 170 1.0× 21 0.3× 24 458
James P. Oberhauser United States 15 211 0.8× 203 0.9× 151 0.7× 74 0.4× 75 0.9× 24 1.0k
H Wendel Germany 12 84 0.3× 110 0.5× 126 0.6× 46 0.3× 37 0.4× 20 417
Alexander A Oliver United States 9 194 0.7× 104 0.4× 132 0.6× 67 0.4× 6 0.1× 27 338
Namheon Lee United States 7 151 0.6× 44 0.2× 207 1.0× 72 0.4× 40 0.5× 9 391

Countries citing papers authored by Claus Harder

Since Specialization
Citations

This map shows the geographic impact of Claus Harder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claus Harder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claus Harder more than expected).

Fields of papers citing papers by Claus Harder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claus Harder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claus Harder. The network helps show where Claus Harder may publish in the future.

Co-authorship network of co-authors of Claus Harder

This figure shows the co-authorship network connecting the top 25 collaborators of Claus Harder. A scholar is included among the top collaborators of Claus Harder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claus Harder. Claus Harder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Lipinski, Michael J., Eduardo Acampado, Qi Cheng, et al.. (2019). Comparison of acute thrombogenicity for magnesium versus stainless steel stents in a porcine arteriovenous shunt model. EuroIntervention. 14(13). 1420–1427. 26 indexed citations
2.
Perron, Aurélien, Caroline Toffolon-Masclet, Thomas Guilbert, et al.. (2014). Understanding sigma-phase precipitation in a stabilized austenitic stainless steel (316Nb) through complementary CALPHAD-based and experimental investigations. Acta Materialia. 79. 16–29. 58 indexed citations
3.
Seidlitz, Anne, Stefan Nagel, Thomas Reske, et al.. (2013). In Vitro Determination of Drug Transfer from Drug-Coated Balloons. PLoS ONE. 8(12). e83992–e83992. 36 indexed citations
4.
Grabow, Niels, Volkmar Senz, Anne Seidlitz, et al.. (2013). Feasibility of Polymer/Drug Coating on Absorbable and Permanent Stent Platforms - Technological Challenges. Biomedizinische Technik/Biomedical Engineering. 58 Suppl 1. 2 indexed citations
5.
Sternberg, Katrin, Niels Grabow, Svea Petersen, et al.. (2013). Advances in Coronary Stent Technology - Active Drug-Loaded Stent Surfaces for Prevention of Restenosis and Improvement of Biocompatibility. Current Pharmaceutical Biotechnology. 14(1). 76–90. 3 indexed citations
6.
Seidlitz, Anne, Volkmar Senz, Niels Grabow, et al.. (2013). Investigating the Applicability of Fluidized-Bed Technology for High-Throughput Coating of Stents. Biomedizinische Technik/Biomedical Engineering. 58 Suppl 1. 1 indexed citations
7.
Sternberg, Katrin, Niels Grabow, Svea Petersen, et al.. (2013). Advances in Coronary Stent Technology - Active Drug-Loaded Stent Surfaces for Prevention of Restenosis and Improvement of Biocompatibility. Current Pharmaceutical Biotechnology. 14(1). 76–90. 19 indexed citations
8.
Seidlitz, Anne, Stefan Nagel, Beatrice Semmling, et al.. (2010). Examination of drug release and distribution from drug-eluting stents with a vessel-simulating flow-through cell. European Journal of Pharmaceutics and Biopharmaceutics. 78(1). 36–48. 31 indexed citations
9.
Schmehl, Jörg, Claus Harder, Hans Peter Wendel, Claus D. Claussen, & Gunnar Tepe. (2008). Silicon carbide coating of nitinol stents to increase antithrombogenic properties and reduce nickel release. Cardiovascular revascularization medicine. 9(4). 255–262. 27 indexed citations
10.
Sternberg, Katrin, Stefan Nagel, Claus Harder, et al.. (2008). Development of a vessel-simulating flow-through cell method for the in vitro evaluation of release and distribution from drug-eluting stents. Journal of Controlled Release. 130(1). 2–8. 35 indexed citations
11.
Waksman, Ron, Rajbabu Pakala, Teruo Okabe, et al.. (2007). Efficacy and Safety of Absorbable Metallic Stents with Adjunct Intracoronary Beta Radiation in Porcine Coronary Arteries. Journal of Interventional Cardiology. 20(5). 367–372. 25 indexed citations
12.
Waksman, Ron, Rajbabu Pakala, Richard Baffour, et al.. (2007). Efficacy and safety of pimecrolimus-eluting stents in porcine coronary arteries. Cardiovascular revascularization medicine. 8(4). 259–274. 7 indexed citations
13.
Waksman, Ron, Rajbabu Pakala, Richard Baffour, et al.. (2007). Effect of pimecrolimus-eluting stent on intimal hyperplasia in porcine coronary arteries. Cardiovascular revascularization medicine. 8(2). 125–125. 1 indexed citations
14.
Waksman, Ron, Rajbabu Pakala, Pramod K. Kuchulakanti, et al.. (2006). Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries. Catheterization and Cardiovascular Interventions. 68(4). 607–617. 268 indexed citations
15.
Waksman, Ron, Rajbabu Pakala, Eric Wittchow, et al.. (2006). Safety and efficacy of bioabsorbable magnesium-alloy stent in porcine coronary arteries: morphometric analysis of a long-term study. Cardiovascular revascularization medicine. 7(2). 92–93. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026